The role of Treg in patients with late-stage HIV disease, who commence combination antiretroviral therapy (cART) and develop pathogen-specific immunopathology manifesting as immune restoration disease (IRD) remains unclear. We hypothesised that Treg could be defective in either numbers and/or function and therefore unable to ensure the physiological equilibrium of the immune system in patients with IRD. Phenotypic and functional CD4+ T-cell subsets of eight late-stage HIV patients with nadir CD4 count <50 cells/μL, who developed mycobacterial IRD upon commencing cART were compared with six therapy naive HIV+ patients (nadir CD4 count <50 cells/μL), who did not develop an IRD after cART. Mycobacteriumavium- specific CD4+ T cells from IRD patients produced high levels of IFN-γ and IL-2 compared with controls (p<0.001). Surprisingly, we found a significant expansion of CD127lo Foxp3+CD25+ Treg in IRD patients and a higher ratio of Treg to effector/memory subsets (p<0.001). In vitro suppression assays demonstrated reduced functional capacity of suppressor cells and diminished IL-10 secretion in IRD patients. Plasma levels of IL-7 were increased in patients and, interestingly, exogenous IL-7 and other cytokines strongly inhibited Treg suppression. These data suggest that despite substantial Treg expansion in IRD, their ability to induce suppression, and thereby downregulate aberrant immune responses, is compromised. © 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
CITATION STYLE
Seddiki, N., Sasson, S. C., Santner-Nanan, B., Munier, M., van Bockel, D., Ip, S., … Kelleher, A. D. (2009). Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease. European Journal of Immunology, 39(2), 391–403. https://doi.org/10.1002/eji.200838630
Mendeley helps you to discover research relevant for your work.